Litcius/Paper detail

Non-alcoholic fatty liver disease is associated with increased risk of chronic kidney disease

Xiaoyan Cai, Lichang Sun, Xiong Liu, Hailan Zhu, Yang Zhang, Sulin Zheng, Yuli Huang

2021Therapeutic Advances in Chronic Disease33 citationsDOIOpen Access PDF

Abstract

BACKGROUND AND AIMS: Whether non-alcoholic fatty liver disease (NAFLD) is associated with an increased risk of incident chronic kidney disease (CKD) independent of established cardio-renal risk factors remains controversial. We aimed to provide a quantitative estimate of the association and strength between NAFLD and risk of CKD after adjustment for multiple cardio-renal risk factors. METHODS: We searched electronic databases (PubMed, Embase, and Google Scholar) for studies published from database inception until 30 November 2020. Analysis included cohort studies that reported multivariable-adjusted risk ratios [including odds ratios, relative risks (RRs), or hazard ratios] and 95% confidence intervals (CIs) for CKD of NAFLD compared with individuals without NAFLD. RESULTS: A total of 11 cohort studies were included comprising 1,198,242 participants (46.3% women) for analysis. The median follow-up duration was 3.7 years, with 31,922 cases of incident CKD. Compared with individuals without NAFLD, unadjusted models showed that NAFLD was associated with a higher risk of CKD (RR 1.54, 95% CI 1.38-1.71). After adjusting for multiple cardio-renal risk factors, the CKD risk was still significantly increased in patients with NAFLD (RR 1.39, 95% CI 1.27-1.52). Compared with individuals without NAFLD, the adjusted absolute risk increase in NAFLD for CKD was 5.1 (95% CI 3.5-6.8) per 1000 person-years. CONCLUSION: NAFLD is associated with an increased risk of incident CKD independent of established cardio-renal risk factors.

Topics & Concepts

MedicineInternal medicineFatty liverKidney diseaseHazard ratioOdds ratioRelative riskRisk factorLower riskCohort studyCohortConfidence intervalDiseaseLiver Disease Diagnosis and TreatmentDiabetes, Cardiovascular Risks, and LipoproteinsLiver Disease and Transplantation